Histopathological Assessment of Wound Healing in Mice Treated with Helianthus Tuberosus Powder
DOI:
https://doi.org/10.5195/d3000.2025.912Λέξεις-κλειδιά:
Inflammation, Medicinal Plants, Wound HealingΠερίληψη
Objective: Several medicinal plants have been given significant attention in the medical field due to their effect on wound healing. This study aims to identify the effectiveness of tuberosus helianthus powder in skin wound healing in mice.
Material and Methods: Tuberosis helianthus powder was purchased from a commercial supplier (medicinal Korean herbs, prince herb). The powder was stored in a dry, airtight container at room temperature until use. It was applied directly to the incisional wounds at a specific concentration and frequency (50 mg twice daily). Thirty-six male mice were randomly assigned to three time points (3, 7, and 14 days), with 12 mice per time point. Each mouse received two incisional wounds: one on the left side, serving as the control, and another on the right side, designated as the experimental wound. At each time point, 12 mice were euthanized, yielding 24 wound samples (12 control and 12 experimental) per time point. In total, 36 control wounds and 36 experimental wounds were analyzed. Three physical parameters were taken, including the number of inflammatory cells, blood vessels, and epidermis thickness. All these parameters were on the dorsal aspect of the thoracolumbar region, into which tuberous helianthus powder was typically done in the treated day duration. Meanwhile, the day durations for control mice were left without any treatment. The mice were euthanized on days 3, 7, and 14 after wound healing for histopathological study.
Results: The histopathological analysis using hematoxylin and eosin (H&E) staining revealed significant differences between the control and treatment groups. On day 3, the control group exhibited pronounced inflammatory responses with extensive inflammatory cell infiltration, necrotic tissue, and fibrin clot formation. In contrast, the treatment group showed early signs of wound healing, such as mild inflammatory response and reepithelialization with keratinized stratified squamous epithelium. Throughout the study, the treatment group demonstrated faster wound contraction, enhanced tissue remodeling, and reduced inflammatory cells compared to the control. By day 14, treated mice displayed mature epidermis and dermal granulation tissue with significant angiogenesis, suggesting accelerated wound healing. These findings support the potential of Helianthus tuberosus powder in promoting wound healing.
Conclusion: Tuberosus helianthus powder plays an important role in the healing pathway in wound healing.
Λήψεις
Δημοσιευμένα
Τεύχος
Ενότητα
Άδεια
Πνευματική ιδιοκτησία (c) 2025 Ali Ismiel Yawir, Layla Sabri Yas
Αυτή η εργασία είναι αδειοδοτημένη υπό το CC Αναφορά Δημιουργού 4.0.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site;
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Revised 7/16/2018. Revision Description: Removed outdated link.
